Chelsea Heights, Australia

Roland Henry Nearn

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Roland Henry Nearn

Introduction

Roland Henry Nearn is a notable inventor based in Chelsea Heights, Australia. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of viral infections. With a total of 2 patents, Nearn's work has the potential to impact public health positively.

Latest Patents

Nearn's latest patents include groundbreaking inventions such as "Bicyclic nucleosides and nucleotides as therapeutic agents." This invention focuses on the use of bicyclic nucleosides and nucleotides based on a specific formula for treating infectious diseases, especially viral infections. Another significant patent is "Polycyclic agents for the treatment of respiratory syncytial virus infections." This patent discloses compounds that can be used in treating infections caused by viruses of the Pneumovirinae sub-family, particularly Respiratory Syncytial Virus (RSV).

Career Highlights

Nearn is currently associated with Biota Scientific Management Pty Ltd, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a strong focus on addressing pressing health challenges through scientific research and development.

Collaborations

Throughout his career, Nearn has collaborated with esteemed colleagues such as Alistair George Draffan and John Nicholas Lambert. These collaborations have further enriched his research and contributed to the advancement of his inventions.

Conclusion

Roland Henry Nearn's contributions to the field of therapeutic agents demonstrate his commitment to innovation and public health. His patents reflect a deep understanding of viral infections and the potential for new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…